Navigating the Antithrombotic Maze: What to do for Your ACS Patients in the Era of Contemporary PCI

Published: 01 September 2020

  • Views:

    Views Icon 56

  • Likes:

    Heart Icon 7
  • episode_image
    Now Playing
    Part 1
    Welcome
    Kurt Huber
    Up Next
  • episode_image
    13m 38s
    Part 5 Q&As
    Kurt Huber, Davide Capodanno, Stefan James, Roxana Mehran
Average (ratings)
No ratings
Your rating

Overview

In this series of videos Kurt Huber, Davide Capodanno, Stefan James and Roxana Mehran discuss Navigating the Antithrombotic Maze: What to do for Your ACS Patients in the Era of Contemporary PCI

Supported by an unrestricted educational grant from AstraZeneca

Learning Objectives

  • Review the clinical landscape for antiplatelet therapy in patients with ACS.
  • Discuss recent data on DAPT for patients with ACS
  • Provide expert insight on application in routine clinical practice

More from this programme

Part 1

Welcome

1 session
Welcome Watch now

Part 2

Pre-treatment in NSTE-ACS – Dead or Alive?

1 session
Pre-treatment in NSTE-ACS – Dead or Alive? Watch now

Part 3

Choice of Antithrombotic Agent in ACS: REACT-ing to Recent Trials

1 session
Choice of Antithrombotic Agent in ACS: REACT-ing to Recent Trials Watch now

Part 4

When to leave Aspirin behind?

1 session
When to leave Aspirin behind? Watch now

Part 5

Q&As

1 session
Q&As Watch now

Faculty Biographies

Kurt Huber

View full profile